Also trades as: EL.PA (PAR) · $vol 119M · ESLOY (OTC) · $vol 12M · EI.SW (SIX) · $vol 0M

$168.91

+10.84 (+6.86%)

Weekly Expected Move ±8.8%

$139 $154 $169 $184 $199

OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 36 · $77.6B mcap · 306M float · 0.0018% daily turnover · Short 35% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Income Trends

Revenue

$28.5B +7.4% ▲

5Y CAGR: +14.6%

Gross Profit

$17.2B +2.6% ▲

5Y CAGR: +15.3%

Operating Income

$3.4B -2.6% ▼

5Y CAGR: +49.4%

Net Income

$2.3B -1.9% ▼

5Y CAGR: +93.6%

EPS (Diluted)

$4.98 -2.9% ▼

5Y CAGR: +92.2%

EBITDA

$6.5B -1.3% ▼

5Y CAGR: +19.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$19.8B	$24.5B	$25.4B	$26.5B	$28.5B
YoY Growth	+37.4%	+23.6%	+3.7%	+4.4%	+7.4%
Cost of Revenue	$7.6B	$8.9B	$9.6B	$9.7B	$11.2B
Gross Profit	$12.2B	$15.6B	$15.8B	$16.8B	$17.2B
Gross Margin	61.7%	63.6%	62.4%	63.4%	60.6%
R&D Expenses	$579M	$871M	$866M	$630M	$664M
SG&A Expenses	$9.2B	$11.7B	$12.0B	$12.5B	$13.2B
Operating Expenses	$10.0B	$12.5B	$12.7B	$13.4B	$13.9B
Operating Income	$2.3B	$3.2B	$3.2B	$3.4B	$3.4B
Operating Margin	11.6%	12.9%	12.5%	13.0%	11.8%
Interest Expense	$141M	$156M	$198M	$165M	$239M
Income Before Tax	$2.2B	$3.0B	$3.0B	$3.3B	$3.2B
Tax Expense	$582M	$751M	$609M	$800M	$752M
Net Income	$1.4B	$2.2B	$2.3B	$2.4B	$2.3B
Net Margin	7.3%	8.8%	9.0%	8.9%	8.1%
EPS (Diluted)	$3.25	$4.83	$5.08	$5.13	$4.98
EBITDA	$4.7B	$6.1B	$6.2B	$6.6B	$6.5B
Shares Outstanding	445M	446M	451M	460M	465M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$12.5B	$12.9B	$12.5B	$13.3B	$13.2B	$14.0B	$14.5B	$14.8B
Cost of Revenue	$4.6B	$4.6B	$4.7B	$4.9B	$4.8B	$5.3B	$6.1B	$5.4B
Gross Profit	$7.9B	$8.2B	$7.8B	$8.4B	$8.4B	$8.7B	$8.4B	$9.4B
Gross Margin	62.9%	64.1%	62.5%	63.3%	63.5%	62.1%	58.1%	63.5%
R&D Expenses	$314M	$300M	$293M	$446M	$184M	$453M	$338M	$333M
SG&A Expenses	$6.1B	$6.0B	$6.1B	$6.1B	$6.4B	$6.4B	$6.6B	$6.8B
Operating Expenses	$6.4B	$6.3B	$6.4B	$6.5B	$6.9B	$6.7B	$7.0B	$7.1B
Operating Income	$1.5B	$1.9B	$1.3B	$1.9B	$1.5B	$2.0B	$1.4B	$2.2B
Operating Margin	11.7%	14.7%	10.7%	14.6%	11.4%	14.3%	9.4%	15.2%
Interest Expense	$80M	$90M	$108M	$244M	$79M	$101M	$196M	$188M
Income Before Tax	$1.4B	$1.8B	$1.3B	$1.9B	$1.4B	$1.9B	$1.3B	$2.2B
Tax Expense	$327M	$322M	$287M	$428M	$372M	$463M	$289M	$541M
Net Income	$979M	$1.4B	$928M	$1.4B	$994M	$1.4B	$928M	$1.6B
Net Margin	7.8%	10.6%	7.4%	10.3%	7.5%	9.9%	6.4%	10.6%
EPS (Diluted)	$2.19	$3.03	$2.05	$2.98	$2.15	$3.00	$1.98	$3.37
EBITDA	$2.2B	$2.4B	$2.4B	$3.0B	$3.6B	$3.0B	$2.9B	$3.8B
Shares Outstanding	448M	449M	453M	459M	460M	462M	469M	464M

ESLOF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet